Trial Profile
Verification of the significance of intervention with ICS/LABA combination therapy in patients with bronchial asthma without inhalation of ICS
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Asthma
- Focus Therapeutic Use
- Acronyms EVOLUTION
- 20 Dec 2010 New trial record